LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
about
Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis.CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?
P2860
LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@en
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@nl
type
label
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@en
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@nl
prefLabel
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@en
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@nl
P2093
P2860
P1433
P1476
LGR5 and CD133 as prognostic a ...... otherapy in colorectal cancer.
@en
P2093
Luka Stanisavljević
Mette P Myklebust
Sabine Leh
P2860
P304
P356
10.1080/0284186X.2016.1201215
P50
P577
2016-07-20T00:00:00Z